We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.1%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$135B
AUM Growth
+$1.6B
(+1.2%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
297
New
11
Increased
80
Reduced
107
Closed
5
Avg Time Held
3.5
years
Top 10 Avg Time Held
3.9
years
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$387M |
| 2 |
Whirlpool
WHR
|
+$305M |
| 3 |
American Airlines Group
AAL
|
+$280M |
| 4 |
Southwest Airlines
LUV
|
+$202M |
| 5 |
iRobot
IRBT
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$1.26B |
| 2 |
Texas Instruments
TXN
|
+$261M |
| 3 |
NVIDIA
NVDA
|
+$238M |
| 4 |
TJX Companies
TJX
|
+$227M |
| 5 |
Visa
V
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.58% |
| 2 | Healthcare | 23.35% |
| 3 | Industrials | 15.29% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Financials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Travelers Companies
TRV
$80.4B
| $48.9M | 0.04% |
399,775
| – | – |
2016 Q2
8 quarters
|
|
177
Charter Communications
CHTR
$12.8B
| $47.9M | 0.04% |
163,300
| – | – |
2016 Q2
8 quarters
|
|
178
Charles River Laboratories
CRL
$14.3B
| $47.6M | 0.04% |
424,100
-200
| -0% | -$21.6K |
2013 Q2
20 quarters
|
|
|
NUVA
179
DELISTED
NuVasive, Inc.
NUVA
| $43.5M | 0.03% |
835,100
| – | – |
2013 Q2
20 quarters
|
|
180
MaxLinear
MXL
$6.59B
| $42.9M | 0.03% |
2,752,862
+1,623,014
| +144% | +$32.8M |
2016 Q4
6 quarters
|
|
181
T-Mobile US
TMUS
$170B
| $42.8M | 0.03% |
715,700
+130,400
| +22% | +$7.72M |
2017 Q1
5 quarters
|
|
182
GSK
GSK
$99.3B
| $42.2M | 0.03% |
837,948
| – | – |
2013 Q2
20 quarters
|
|
183
Gildan
GIL
$7.75B
| $41.8M | 0.03% |
1,484,500
-10,000
| -0.7% | -$290K |
2014 Q2
16 quarters
|
|
184
Norfolk Southern
NSC
$72.7B
| $41.5M | 0.03% |
275,000
| – | – |
2013 Q2
20 quarters
|
|
185
Stryker
SYK
$113B
| $38.1M | 0.03% |
225,500
| – | – |
2013 Q2
20 quarters
|
|
186
DELISTED
Immunogen Inc
IMGN
| $37.2M | 0.03% |
3,823,300
| – | – |
2013 Q2
20 quarters
|
|
187
nVent Electric
NVT
$23.2B
| $36.8M | 0.03% |
+1,467,390
| New | +$38.2M |
2018 Q2
0 quarters
|
|
|
ASNA
188
DELISTED
Ascena Retail Group, Inc.
ASNA
| $36.5M | 0.03% |
458,150
| – | – |
2013 Q2
20 quarters
|
|
189
Axon Enterprise
AXON
$32.6B
| $36.1M | 0.03% |
572,000
-30,000
| -5% | -$1.62M |
2016 Q2
8 quarters
|
|
190
Tyson Foods
TSN
$19.3B
| $35.5M | 0.03% |
515,000
-8,600
| -2% | -$598K |
2014 Q4
14 quarters
|
|
191
NMI Holdings
NMIH
$3.05B
| $35.4M | 0.03% |
2,174,049
+1,447,239
| +199% | +$23.4M |
2017 Q4
2 quarters
|
|
192
DELISTED
Altair Engineering Inc
ALTR
| $34.6M | 0.03% |
1,012,400
| – | – |
2017 Q4
2 quarters
|
|
193
Standard BioTools
LAB
$252M
| $34.5M | 0.03% |
5,792,043
+5,000
| +0.1% | +$28.5K |
2013 Q2
20 quarters
|
|
194
General Dynamics
GD
$92.4B
| $32.1M | 0.02% |
172,000
+99,000
| +136% | +$20.3M |
2016 Q4
6 quarters
|
|
195
Old Dominion Freight Line
ODFL
$38.7B
| $30.2M | 0.02% |
609,000
| – | – |
2017 Q2
4 quarters
|
|
196
DELISTED
Hawaiian Holdings, Inc.
HA
| $29.9M | 0.02% |
831,500
| – | – |
2014 Q2
16 quarters
|
|
197
Altria Group
MO
$125B
| $29.8M | 0.02% |
525,404
-2,800
| -0.5% | -$161K |
2017 Q2
4 quarters
|
|
198
Arbutus Biopharma
ABUS
$836M
| $29.2M | 0.02% |
4,000,400
| – | – |
2015 Q1
13 quarters
|
|
199
NOV
NOV
$6.74B
| $28.4M | 0.02% |
653,566
-3,100
| -0.5% | -$125K |
2013 Q2
20 quarters
|
|
200
OraSure Technologies
OSUR
$252M
| $24.6M | 0.02% |
1,494,000
+228,000
| +18% | +$3.85M |
2013 Q2
20 quarters
|
|
Similar funds
Primecap Management's Q2 2018 Portfolio in Review
As of Q2 2018, Primecap Management held 297 positions worth $135B, up 1.2% from $133B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Primecap Management's Q2 2018 filing shows 11 new, 80 increased, 107 reduced and 5 closed positions. Its largest new stake was Perspecta Inc. Common Stock: 2,453,912 shares worth $50.4M. The largest sale was Monsanto Co, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2018 buy was Perspecta Inc. Common Stock: 2,453,912 shares worth $50.4M.
- Primecap Management added most to Wells Fargo in Q2 2018, an estimated $387M increase.
- Primecap Management's biggest Q2 2018 reduction was Texas Instruments, cutting an estimated $261M.
- Primecap Management fully exited Monsanto Co in Q2 2018, selling an estimated $1.26B.
- Primecap Management's ten largest holdings make up 29% of its $135B portfolio in Q2 2018.
- Primecap Management opened 11 new positions and closed 5 in Q2 2018.
- Primecap Management's portfolio value rose 1.2% quarter-over-quarter to $135B.
Based on Primecap Management's 13F filing for Q2 2018, filed 13 Aug 2018.